journal article·2019-12-04Open access

Silver/silver chloride (Ag/AgCl) nanoparticles synthesized from Azadirachta indica lalex and its antibiofilm activity against fluconazole resistant Candida tropicalis

Mohammed Saleh Al Aboody

Abstract

In this study, latex of Azadirachta indica was used for the synthesis of silver nanoparticles (AgNP). UV-visible spectroscopy revealed the formation of AgNPs and the absorption band optimized at 442 nm. Fourier transform infrared (FTIR) spectroscopy shows different functional groups (carboxyl, amine and hydroxyl) of biomolecule which are responsible for reduction and capping process. X-ray diffraction (XRD) analysis confirms the nanoparticles are crystalline silver and cubic (AgCl) with face-centered cubic (Ag) types. Electron microscopics (SEM and TEM) were used to characterize the shape and size of the nanoparticles. The anticandidal and antibiofilm activity of AgNPs was using Fluconazole resistant clinical isolate of Candida tropicalis. The new approach of plant-mediated AgNPs synthesis appears to be cost-effective, eco-friendly and easy methods. The synthesized AgNPs considered as a novel and alternative agent to prevent C. tropicalis biofilms.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Dielectric properties of ceramics · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biology, College of Science, Al-Zulfi-, Majmaah University

Funding

Majmaah University

References (42)

Show source-provided references
1. 10.1002/9783527679577.ch1710.1002/9783527679577.ch17 ↗
2. 10.1016/j.tibtech.2013.01.00310.1016/j.tibtech.2013.01.003 ↗
3. 10.1039/b502142c10.1039/b502142c ↗
4. 10.1007/s00775-018-1542-z10.1007/s00775-018-1542-z ↗
5. 10.1166/asem.2017.202710.1166/asem.2017.2027 ↗
6. 10.3390/molecules2311303210.3390/molecules23113032 ↗
7. 10.1021/nl050556q10.1021/nl050556q ↗
8. 10.1021/nl025547l10.1021/nl025547l ↗
9. 10.1021/cr068077e10.1021/cr068077e ↗
10. 10.1016/j.colsurfb.2012.11.04110.1016/j.colsurfb.2012.11.041 ↗
11. 10.1155/2011/31962410.1155/2011/319624 ↗
12. 10.1016/j.colsurfb.2013.01.00310.1016/j.colsurfb.2013.01.003 ↗
13. 10.22159/ajpcr.2016.v9i6.1356710.22159/ajpcr.2016.v9i6.13567 ↗
14. 10.1590/S0036-4665201500020001110.1590/S0036-46652015000200011 ↗
15. Suresh M, Rath PK, Panneerselvam A, et al. Antifungal activity of selected Indian medicinal plant salts. J Glob Pharma Technol. 2010;2:71–74.
16. 10.3390/insects1001002710.3390/insects10010027 ↗
17. 10.18632/oncotarget.2385910.18632/oncotarget.23859 ↗
18. 10.3389/fmicb.2017.0192710.3389/fmicb.2017.01927 ↗
19. Jacobs PH and Nall L, editors. Antifungal drug therapy: a complete guide for the practitioner. New York: Marcel Dekker; 1990. p. 32–45.
20. 10.1007/s12281-013-0133-210.1007/s12281-013-0133-2 ↗
21. Pendleton KM, Huffnagle GB, Dickson RP. The significance of Candida in the human respiratory tract: our evolving understanding. Pathogens Dis. 2017;75:ftx029.
22. 10.1128/CMR.00076-0910.1128/CMR.00076-09 ↗
23. 10.3390/jof401002210.3390/jof4010022 ↗
24. 10.1097/00000441-199310000-0000410.1097/00000441-199310000-00004 ↗
25. 10.1371/journal.pone.009910310.1371/journal.pone.0099103 ↗
26. Mohammadi R, Foroughifar E. Candida infections among neutropenic patients. Caspian J Int Med. 2016;7:71.
27. 10.3390/jof301000810.3390/jof3010008 ↗
28. 10.1080/21691401.2017.132868810.1080/21691401.2017.1328688 ↗
29. 10.1016/j.archoralbio.2016.09.00310.1016/j.archoralbio.2016.09.003 ↗
30. 10.2147/IDR.S16426210.2147/IDR.S164262 ↗
31. 10.1007/s12010-012-9710-z10.1007/s12010-012-9710-z ↗
32. 10.18311/jsst/2016/1545210.18311/jsst/2016/15452 ↗
33. 10.1007/s00436-012-2867-010.1007/s00436-012-2867-0 ↗
34. 10.12980/APJTB.4.201414B21610.12980/APJTB.4.201414B216 ↗
35. Iravani S, Korbekandi H, Mirmohammadi SV, et al. Synthesis of silver nanoparticles: chemical, physical and biological methods. Res Pharm Sci. 2014;9:385.
36. 10.1016/j.saa.2012.06.03810.1016/j.saa.2012.06.038 ↗
37. 10.1016/j.saa.2009.02.03710.1016/j.saa.2009.02.037 ↗
38. 10.1007/s12010-012-9877-310.1007/s12010-012-9877-3 ↗
39. 10.1016/j.cis.2008.09.00210.1016/j.cis.2008.09.002 ↗
40. 10.1080/17458080.2017.133589010.1080/17458080.2017.1335890 ↗
41. 10.1038/srep2666710.1038/srep26667 ↗
42. 10.1021/ac400486u10.1021/ac400486u ↗